SCHEMBL23055259

SCHEMBL23055259

CC(C)Nc1ccn2nccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 7/20 0.43
RIPK1 Q13546 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
MAP4K4 O95819 1/20 0.37
SCN5A Q14524 1/20 0.37
MKNK1 Q9BUB5 3/20 0.36
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
CYP3A4 P08684 1/20 0.35
THRB P10828 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
ALOX12 P18054 1/20 0.35
RECQL P46063 1/20 0.35
ATM Q13315 1/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
DRD2 P14416 2/20 0.35
DRD1 P21728 2/20 0.35
DRD4 P21917 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15120373 0.80 RIPK1 (0.42) IRAK4RIPK1MAP4K4SCN5AMKNK1
SCHEMBL20814388 0.78 POLB (0.58) IRAK4TDP1LMNA
SCHEMBL16368638 0.76 IRAK4 (0.44) IRAK4RIPK1SCN5AMKNK1DRD2
SCHEMBL23055240 0.75 TDP1 (0.34) IRAK4TDP1MAP4K4ALDH1A1LMNA
SCHEMBL24783502 0.74 TDP1 (0.41) IRAK4TDP1MAP4K4ALDH1A1LMNA
SCHEMBL15686694 0.73 SCN5A (0.40) IRAK4RIPK1TDP1SCN5AALDH1A1
SCHEMBL25124503 0.71 MAP4K4 (0.46) TDP1MAP4K4LMNATSHRRECQL
SCHEMBL25475739 0.71 SCN5A (0.36) RIPK1SCN5ADRD2DRD1DRD4
SCHEMBL2179468 0.70 SCN5A (0.38) RIPK1SCN5ADRD2DRD1DRD4
SCHEMBL12489666 0.70 UGT2B7 (0.39) IRAK4RIPK1SCN5ADRD2DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021149767-A1 HETEROCYCLIC DERIVATIVE 大日本住友製薬株式会社 2021-07-29 WO disclosed
WO-2021039961-A1 RING-FUSED PYRAZOLE DERIVATIVE 大日本住友製薬株式会社 2021-03-04 WO disclosed